Nada Ghosn

616 total citations
33 papers, 364 citations indexed

About

Nada Ghosn is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nada Ghosn has authored 33 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nada Ghosn's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 epidemiological studies (5 papers) and Salmonella and Campylobacter epidemiology (5 papers). Nada Ghosn is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 epidemiological studies (5 papers) and Salmonella and Campylobacter epidemiology (5 papers). Nada Ghosn collaborates with scholars based in Lebanon, France and Egypt. Nada Ghosn's co-authors include Atika Berry, Umayya Musharrafıeh, Abdul Rahman Bizri, Ali Alawieh, Alissar Rady, Ibrahim Khalifeh, Khalil M. Charafeddine, Robert Habib, Ghassan M. Matar and Walid Ammar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Emerging infectious diseases.

In The Last Decade

Nada Ghosn

31 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nada Ghosn Lebanon 10 173 116 90 50 32 33 364
Keflemariam Yohannes Australia 12 111 0.6× 114 1.0× 153 1.7× 76 1.5× 36 1.1× 16 388
Theologia Sideroglou Greece 12 117 0.7× 93 0.8× 185 2.1× 101 2.0× 32 1.0× 26 439
Edwin Afari Ghana 14 296 1.7× 52 0.4× 67 0.7× 64 1.3× 68 2.1× 32 518
Shama Cash‐Goldwasser United States 10 140 0.8× 131 1.1× 124 1.4× 61 1.2× 98 3.1× 23 445
April K. Bogard United States 7 75 0.4× 112 1.0× 136 1.5× 52 1.0× 115 3.6× 8 370
Lisa A. Lee United States 11 45 0.3× 140 1.2× 173 1.9× 44 0.9× 23 0.7× 13 528
Charmaine Gauci Malta 10 64 0.4× 75 0.6× 206 2.3× 170 3.4× 19 0.6× 29 468
Parvathy Nair United States 9 139 0.8× 52 0.4× 135 1.5× 38 0.8× 25 0.8× 16 375
Julia Lynch United States 14 179 1.0× 133 1.1× 300 3.3× 44 0.9× 13 0.4× 42 626
Joana Gomes Dias Sweden 10 83 0.5× 252 2.2× 170 1.9× 51 1.0× 36 1.1× 19 561

Countries citing papers authored by Nada Ghosn

Since Specialization
Citations

This map shows the geographic impact of Nada Ghosn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Ghosn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Ghosn more than expected).

Fields of papers citing papers by Nada Ghosn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Ghosn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Ghosn. The network helps show where Nada Ghosn may publish in the future.

Co-authorship network of co-authors of Nada Ghosn

This figure shows the co-authorship network connecting the top 25 collaborators of Nada Ghosn. A scholar is included among the top collaborators of Nada Ghosn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada Ghosn. Nada Ghosn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tempia, Stefano, et al.. (2023). Estimation of the influenza‐associated respiratory hospitalization burden using sentinel surveillance data, Lebanon, 2015–2020. Influenza and Other Respiratory Viruses. 17(4). e13138–e13138. 5 indexed citations
3.
Page, Andrew J., Martin Lott, Nada Ghosn, et al.. (2023). Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon. BMC Medical Genomics. 16(1). 14–14. 7 indexed citations
4.
Abou‐Abbas, Linda, et al.. (2022). COVID-19 mortality surveillance in Lebanon. Scientific Reports. 12(1). 14639–14639. 2 indexed citations
6.
Feghali, Rita, Georgi Merhi, Aurélia Kwasiborski, et al.. (2021). Genomic characterization and phylogenetic analysis of the first SARS-CoV-2 variants introduced in Lebanon. PeerJ. 9. e11015–e11015. 16 indexed citations
7.
Clapham, Hannah, et al.. (2021). Calculating the serial interval of SARS-CoV-2 in Lebanon using 2020 contact-tracing data. BMC Infectious Diseases. 21(1). 1053–1053. 5 indexed citations
8.
Berry, Atika, et al.. (2021). Phased repatriation of Lebanese expatriates stranded abroad during coronavirus disease 2019 (COVID-19) pandemic. Archives of Public Health. 79(1). 206–206. 4 indexed citations
9.
Musharrafıeh, Umayya, et al.. (2021). The Association Between the Syrian Crisis and Cutaneous Leishmaniasis in Lebanon. Acta Parasitologica. 66(4). 1240–1245. 17 indexed citations
10.
Fadlallah, Sukayna, Katia Cheaito, Zeina Nasser, et al.. (2019). PulseNet Lebanon: An Overview of Its Activities, Outbreak Investigations, and Challenges. Foodborne Pathogens and Disease. 16(7). 498–503. 8 indexed citations
11.
Fadlallah, Sukayna, et al.. (2017). Molecular epidemiology and antimicrobial resistance of Salmonella species from clinical specimens and food Items in Lebanon. The Journal of Infection in Developing Countries. 11(1). 19–27. 13 indexed citations
12.
Elkholy, Amgad, Alissar Rady, Wasiq Khan, et al.. (2017). Influenza‐associated severe acute respiratory infections in 2 sentinel sites in Lebanon—September 2015 to August 2016. Influenza and Other Respiratory Viruses. 12(3). 331–335. 9 indexed citations
13.
Kissoyan, Kohar Annie B., et al.. (2016). Genotypic and virulence characteristics of Listeria monocytogenes recovered from food items in Lebanon. The Journal of Infection in Developing Countries. 10(7). 712–717. 8 indexed citations
14.
Bizri, Abdul Rahman, et al.. (2016). Salmonellaburden in Lebanon. Epidemiology and Infection. 144(8). 1761–1769. 13 indexed citations
15.
Mansour, Anthony G., et al.. (2016). National study on the adequacy of antidotes stocking in Lebanese hospitals providing emergency care. BMC Pharmacology and Toxicology. 17(1). 51–51. 3 indexed citations
16.
Alawieh, Ali, et al.. (2014). Revisiting leishmaniasis in the time of war: the Syrian conflict and the Lebanese outbreak. International Journal of Infectious Diseases. 29. 115–119. 93 indexed citations
17.
Bizri, Abdul Rahman, Ali Alawieh, Nada Ghosn, Atika Berry, & Umayya Musharrafıeh. (2013). Challenges facing human rabies control: the Lebanese experience. Epidemiology and Infection. 142(7). 1486–1494. 9 indexed citations
18.
Carayol, Marion, et al.. (2008). Determinants of caesarean section in Lebanon: geographical differences. Paediatric and Perinatal Epidemiology. 22(2). 136–144. 10 indexed citations
19.
Ghosn, Nada, et al.. (2008). Electronic surveillance of outbreaks in Lebanon. BMC Proceedings. 2(S3). S2–S2. 7 indexed citations
20.
Blondel, Béatrice, et al.. (2006). Collecting population‐based perinatal data efficiently: the example of the Lebanese National Perinatal Survey. Paediatric and Perinatal Epidemiology. 20(5). 416–424. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026